Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Convertible Redeemable Preferred Stock Series A [Member]
Convertible Redeemable Preferred Stock Series B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance at Dec. 31, 2020 $ 961 $ 672,304 $ (570,704) $ (10) $ 102,551
Beginning balance, shares at Dec. 31, 2020 3,845,267        
Stock-based compensation expense 8,916 8,916
Issuance of common stock in connection with the exercise of stock options $ 6 825 831
Issuance of common stock in connection with the exercise of stock options, shares     25,227        
Issuance of common stock in connection with restricted share awards, net of cancellations $ 21 (21)
Issuance of common stock in connection with restricted share awards, net of cancellations, shares     82,851        
Issuance of common stock and stock purchase warrants in connection with public offering, net of offering costs and warrant liability $ 447 6,525 6,972
Issuance of common stock and stock purchase warents in connection with public offering net of offering costs and warrant liability, shares     1,788,000        
Issuance of common stock, net of offering costs under open market sale agreement (ATM) $ 37 8,014 8,051
Issuance of common stock, net of offering costs under open market sale agreement, shares     146,872        
Net loss (84,936) (84,936)
Other comprehensive loss (17) (17)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock            
Ending Balance at Dec. 31, 2021 $ 1,472 696,563 (655,640) (27) 42,368
Ending balance, shares at Dec. 31, 2021 5,888,217        
Stock-based compensation expense 3,051 3,051
Issuance of common stock, net of offering costs under open market sale agreement (ATM) $ 35 12,804 12,839
Issuance of common stock, net of offering costs under open market sale agreement, shares     3,479,016        
Net loss (39,696) (39,696)
Other comprehensive loss (102) (102)
Issuance of common stock in connection with restricted share awards, net of cancellations and shares settled for tax withholding settlement $ 2 (7) (5)
Issuance of common stock in connection with restricted share awards, net of cancellations and shares settled for tax witholding settlement, shares     742,608        
Issuance of common stock and stock purchase warrants in connection with private placement offering, net of offering costs and warrant liability $ 76 12,012 12,088
Issuance of common stock and stock purchase warrants in connection with private placement offering, net of offering costs and warrant liability, shares     7,609,879        
Issuance of Series A and Series B Convertible Redeemable Preferred Stock $ 17,974 $ 4,494
Issuance of Series A and Series B Convertible Redeemable Preferred Stock, net of issuance costs, shares 1,000,006 250,005          
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock $ 3,026 $ 756 (3,782) (3,782)
Redemption of Series A and Series B Convertible Redeemable Preferred Stock $ (21,000) $ (5,250)
Redemption of Series A and Series B Convertible Redeemable Preferred Stock, shares (1,000,006) (250,005)          
Reverse stock split adjustment (1,408) 1,408
Ending Balance at Dec. 31, 2022 $ 177 $ 722,049 $ (695,336) $ (129) $ 26,761
Ending balance, shares at Dec. 31, 2022 17,719,720